56m
Khaleej Times on MSNFintech and financial literacy hold the future of paymentsUncover the future of payments as fintech transforms financial management in the UAE. Learn about the importance of financial ...
By December 2024, an ActBlue sheet tallying just the “known instances of fraud” revealed hundreds of donations — including ...
Forest fires were once a rarity, but now break out regularly during Germany's hotter months. Could a new tech solution help ...
Republicans began investigating ActBlue, the Democratic Party’s main fund-raising platform, last year in part of a broader ...
A structured mediation process helps clarify issues, ensuring a constructive dialogue rather than an adversarial ...
Conformal Medical, Inc., a medical device company specializing in stroke prevention technology, announces the enrollment of ...
8h
Study Finds on MSNThe Great Aspirin Debate: Why Age-Based Guidelines Are Being QuestionedResearchers from Florida Atlantic University argue that doctors should consider each patient's individual risk profile rather ...
Append Medical, a leader in innovative solutions for Left Atrial Appendage (LAA) occlusion, is proud to announce the ...
6h
The New Republic on MSN“Fertilization President” Trump Just Gutted Fertility ResearchThe cut comes barely a week after Trump referred to himself as the “fertilization president” during a Women’s History Month ...
18h
NBC4 WCMH-TV on MSNHIV funding cuts will hinder Ohio treatment and prevention, LGBTQ+ health group saysAn Ohio healthcare system tailored to the LGBTQ+ community says federal cuts to HIV funding could undo progress in treating ...
ActBlue adopted 'more lenient' donation standards, received foreign money during 2024 election cycle
Three House Committees launched probes last year after reviewing evidence that the platform accepted donations from foreign ...
Jyong Biotech Ltd. (Revived IPO) (MENS) expects to raise $22 million in an IPO on the week of April 7th, IPO Scoop reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results